Indavire 400 Capsule contains Indinavir sulphate 400mg, a protease inhibitor widely used in the management of HIV infection. It works by inhibiting the HIV protease enzyme, preventing viral replication and helping maintain viral suppression when used in combination antiretroviral therapy.
This formulation is essential for maintaining effective viral load control and improving immune function in HIV-positive patients. Its well-studied efficacy ensures reliable therapeutic outcomes as part of combination regimens prescribed by infectious disease specialists.
For distributors and hospital suppliers, Indavire 400 Capsule is a high-demand antiretroviral product, regularly required in HIV clinics, ART centers, government programs, and private hospitals. Consistent patient adherence to therapy ensures ongoing market demand.
Adding Indavire 400 Capsule to your antiretroviral and HIV-care segment strengthens your portfolio, opening opportunities in pharmacy distribution, hospital procurement, institutional supply, export markets, and third-party manufacturing. Its critical role in HIV treatment makes it a commercially valuable addition for pharmaceutical distributors.